Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Cash & Equivalents (2016 - 2026)

Inogen has reported Cash & Equivalents over the past 14 years, most recently at $103.7 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 8.85% to $103.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.7 million through Dec 2025, down 8.85% year-over-year, with the annual reading at $103.7 million for FY2025, 8.85% down from the prior year.
  • Cash & Equivalents was $103.7 million for Q4 2025 at Inogen, down from $106.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $241.6 million in Q3 2021 and troughed at $23.7 million in Q3 2023.
  • The 5-year median for Cash & Equivalents is $144.8 million (2023), against an average of $155.4 million.
  • Year-over-year, Cash & Equivalents plummeted 88.68% in 2023 and then surged 345.22% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $235.5 million in 2021, then fell by 20.6% to $187.0 million in 2022, then crashed by 32.9% to $125.5 million in 2023, then decreased by 9.32% to $113.8 million in 2024, then fell by 8.85% to $103.7 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's Cash & Equivalents are $103.7 million (Q4 2025), $106.5 million (Q3 2025), and $103.7 million (Q2 2025).